论文信息 - Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma. - 字舞流文

Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma.

M. Brock | Q. Mei | W. Han | Xiaojing An | Chun-meng Wang | Yang Liu | Liang Dong | Xiang Li | Jiejie Liu | Yan Zhang | Qing-ming Yang | Mei-xia Chen | J. Bai | J. Nie | Lu Shi | Wenjing Ku | Meixia Chen | Chunmeng Wang